Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$14.8500
-0.2700 (-1.7857%)
- Prev. close
- 15.1200
- Volume
- 399,582
- High
- 15.2100
- Capitalization
- 639.132M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€12.8300
+0.2500 (1.9873%)
- Prev. close
- 12.5800
- Volume
- 63,676
- High
- 12.8800
- Capitalization
- 545.136M
Covering research analysts
Barclays - Gena Wang
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter& Elisabeth Webster
Guggenheim - Michael Schmidt & Kelsey Goodwin
Jones Trading - Soumit Roy
Kempen - Ingrid Gafanhão
Ladenburg – Wangzhi Li
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
Portzamparc – Christophe Dombu
RW Baird - Jack Allen & Brian Skorney
Wells Fargo – Nick Abbott
William Blair – Raju Prasad
Cellectis contact information
Simon Harnest
Investor Relations USA
+1 646 385 9008
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89